Quarter Period Consolidated Statement Of Income

BrightPath Biotherapeutics Co., Ltd. - Filing #7591778

Concept 2022-04-01 to
2022-06-30
2021-04-01 to
2021-06-30
Quarter period consolidated statement of income
Statement of income
Net sales
106,000 JPY
212,000 JPY
Cost of sales
26,000 JPY
53,000 JPY
Gross profit (loss)
79,000 JPY
159,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
545,503,000 JPY
402,732,000 JPY
Operating profit (loss)
-545,423,000 JPY
-402,573,000 JPY
Non-operating income
Non-operating income
308,000 JPY
8,000 JPY
Non-operating expenses
Non-operating expenses
3,106,000 JPY
1,339,000 JPY
Ordinary profit (loss)
-548,221,000 JPY
-403,904,000 JPY
Extraordinary income
Extraordinary income
JPY
4,455,000 JPY
Extraordinary losses
Impairment losses
JPY
2,896,000 JPY
Extraordinary losses
JPY
2,933,000 JPY
Profit (loss) before income taxes
-548,221,000 JPY
-402,383,000 JPY
Income taxes - current
475,000 JPY
605,000 JPY
Income taxes
475,000 JPY
605,000 JPY
Profit (loss)
-548,696,000 JPY
-402,988,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.